Cargando…
Empagliflozin activates Wnt/β-catenin to stimulate FUNDC1-dependent mitochondrial quality surveillance against type-3 cardiorenal syndrome
OBJECTIVES: Cardiorenal syndrome type-3 (CRS-3) is an abrupt worsening of cardiac function secondary to acute kidney injury. Mitochondrial dysfunction is a key pathological mechanism of CRS-3, and empagliflozin can improve mitochondrial biology by promoting mitophagy. Here, we assessed the effects o...
Autores principales: | Cai, Chen, Wu, Feng, Zhuang, Bingjie, Ou, Qing, Peng, Xiaojie, Shi, Nengxian, Peng, Lan, Li, Ziying, Wang, Jin, Cai, Shumin, Tan, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372775/ https://www.ncbi.nlm.nih.gov/pubmed/35863636 http://dx.doi.org/10.1016/j.molmet.2022.101553 |
Ejemplares similares
-
Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway
por: Cai, Chen, et al.
Publicado: (2022) -
Corrigendum to “Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway” [Redox Biol. 52 (2022) 102288]
por: Cai, Chen, et al.
Publicado: (2023) -
Mitochondrial quality control in diabetic cardiomyopathy: from molecular mechanisms to therapeutic strategies
por: Cai, Chen, et al.
Publicado: (2022) -
Irisin Attenuates Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in the H9C2 Cellular Model of Septic Cardiomyopathy through Augmenting Fundc1-Dependent Mitophagy
por: Jiang, Xiaoqing, et al.
Publicado: (2021) -
The multi-faced role of FUNDC1 in mitochondrial events and human diseases
por: Tan, Nannan, et al.
Publicado: (2022)